How Schurter helped Biotronik develop the Renamic Neo
Electromagnetic compatibility was important in developing the device, which uses Schurter components with low electromagnetic radiation.
Stay updated with breaking news from Renamic Neo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Electromagnetic compatibility was important in developing the device, which uses Schurter components with low electromagnetic radiation.
/PRNewswire/ -- The global active implantable medical devices market was worth around USD 85.31 billion in 2021 and is estimated to grow to about USD 143.10...
/PRNewswire/ -- BIOTRONIK, Inc. announced today it has received U.S. Food and Drug Administration (FDA) approval of Renamic Neo, the company's state-of-the-art...
Biotronik announced today that the FDA approved its Renamic Neo programmer for implanted cardiac rhythm management devices.
NORTHUMBRIA Healthcare is leading the way for Europe in heart technology.